The Master formulary is based on the formats used within the British National Formulary. The first edition of the Master formulary is based on the most recent formulary produced by Dr Richard Hain and Dr Sat Jassal for the Oxford Handbook of Paediatric Palliative Medicine which has in turn adopted indications, routes and dose recommendations from the BNFC unless research evidence or expert consensus suggested otherwise.
The first edition Master Formulary Group comprises:
- Anita Aindow, Specialist Pharmacist, Alder Hey Children’s Hospital
- Lynda Brook, Consultant in Paediatric Palliative Medicine, Alder Hey Children’s Hospital
- Finella Craig, Consultant in Paediatric Palliative Medicine, Great Ormond Street Hospital, London
- Richard Hain, Consultant in Paediatric Palliative Medicine, Cardiff
- Sat Jassal, Medical Director Rainbows Children's Hospice, Loughborough
- Susie Lapwood, Medical Director Helen and Douglas House Hospices for children and young adults, Oxford
Publication of the Master Formulary
- Authors of the other related formularies for paediatric palliative medicine have agreed to update their publications to be in line with the Master formulary
- o The Oxford Textbook of Paediatric Palliative Care
- o Rainbows Children's Hospice Symptom Control Manual
- o The Oxford Handbook of Palliative Medicine in the Paediatric chapter
- o
- o Alder Hey Hospital local guidelines
Updating the Master Formulary
It is essential that the APPM Master Formulary is regularly updated in line with research evidence and expert opinion. In order to achieve this the Master Formulary Group will:
- Undertake an annual survey of current prescribing practice in paediatric palliative care to identify contentious areas and areas of professional concern
- Undertake a systematic review for each drug, dose or indication identified in the survey
- Undertake a Delphi survey to develop consensus around contentious areas or areas of professional concern
- Prospectively collect information on novel uses routes, doses and adverse drug reactions using system similar to yellow card or RCPCH surveillance scheme
- Present clearly options where there is no current consensus or where different doses are recommended for different situations
The first annual survey is now live and can be accessed via the APPM website www.act.org.uk/APPM
Sat Jassal This e-mail address is being protected from spambots. You need JavaScript enabled to view it and Lynda Brook This e-mail address is being protected from spambots. You need JavaScript enabled to view it
April 2011






